Neonatal jaundice is a condition that causes infants' skin to turn yellow within the first few days of life. The yellowish colour is caused by a rise in bilirubin's blood pigment, which settles in the skin. This is a common occurrence that affects roughly 2/3 of all healthy babies. It could, however, be an indication of an issue with the baby's eating, hydration, or red blood cell longevity. Other rare causes of jaundice include metabolic abnormalities, gland malfunction, and liver disease. Light therapy, intravenous immunoglobulin, and exchange transfusion are among of the most popular treatments for this condition.
Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/global-neonatal-jaundice-management-market
Data Bridge Market Research analyses that the neonatal jaundice management market is expected to grow at a CAGR of 6.40% in the forecast period of 2021 to 2028 and is expected to reach USD 555.54 million by 2028. The increase in the technological advancements in the infant phototherapy devices and surge in funding on healthcare infrastructure are boosting the neonatal jaundice management market. Furthermore, the increase in the funding by the federal government and advanced healthcare regulatory scenarios will provide up significant market potential.
Rising prevalence rate of neonatal jaundice is expected to drive the market's growth rate during the forecast period.
Infants born before 37 weeks of pregnancy are more likely to develop jaundice due to their underdeveloped liver, which produces excess bilirubin. Factors such as these and a significant focus on developing innovative instruments to detect bilirubin levels in jaundiced babies will help to spread the use of infant jaundice phototherapy. Phototherapy is one of the most successful and simple ways to cure new-born jaundice in infants. It is often used in neonates to lower bilirubin levels. The bilirubin in the infant's body is transformed into a water-soluble form that may be easily expelled through stool and urine during this process. Because phototherapy involves exposing the infant's body to particular lights that help transform bilirubin into a form that can be easily flushed out through urine, it reduces certain side effects such as mild allergic reactions, fever owing to infection, and changes in blood composition.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2021 to 2028
|
|
Base Year
|
2020
|
|
Historic Years
|
2019 (Customizable to 2013 - 2018)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Primary Care, Secondary Care), Technology (Light-Emitting Diode Light Sources, Fluorescent, Halogen and Fiberoptic), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Users and Others), Distribution Channel (Direct Tender, Retail Sales and Third Party Distribution)
|
|
Countries Covered
|
U.S., Canada, Mexico, U.K., Germany, Italy, France, Spain, Russia, Netherland, Switzerland, Turkey, Belgium, Rest of Europe, China, India, Japan, Australia, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
Medical Corp. (U.S.), avihealthcare (India), GENERAL ELECTRIC COMPANY (U.S.), Ibis Medical (India), Natus Medical Incorporated (U.S.), Ningbo David Medical (China), Weyer GmbH (Germany), Signify Holding (Netherlands), nice Neotech Medical Systems Pvt. Ltd. (India), Phoenix Medical Systems (P) Ltd (India), Solarc Systems Inc. (Canada)
|
|
Data Pointers Covered in Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The neonatal jaundice management market is segmented on the basis of type, technology, end user and distribution channel.
- On the basis of type, the neonatal jaundice management market is segmented into primary care and secondary care. In 2021, primary care segment is expected to dominate the market with 58.06% market share because primary care is the common and initial criteria for the neonate care suffering from jaundice.
In 2021, the primary care segment of type segment is anticipated to dominate the neonatal jaundice management market.
In 2021, the primary care segment of this market will dominate the neonatal jaundice management market because primary care is the common and initial criteria for the neonate care suffering from jaundice. The primary care segment is expected reach the highest CAGR of 6.6% in the forecast period of 2021-2028.
- On the basis of technology, the neonatal jaundice management market is segmented into fluorescent, halogen, fiberoptic, light-emitting diode light sources, and others. In 2021, light-emitting diode light sources segment is expected to dominate the market with 57.79% market share as most of the healthcare facilities have LED based products and these product are highly effective.
- On the basis of end user, the neonatal jaundice management market is segmented into hospitals, clinics, ambulatory surgery centers, home users and others. In 2021, the hospitals segment is expected to dominate the market with 48.45% market share because of the presence of highly specialized professionals and well-equipped technology for the treatment of neonatal jaundice.
- On the basis of distribution channel, the neonatal jaundice management market is segmented into direct tender, retail sales, and third party distribution. In 2021, the direct tender segment is expected to dominate the market with 68.37% market share because phototherapy devices or equipment are costly and require multiple vendor analysis to purchase the device.
In 2021, the direct tender segment is projected to hold the largest share of distribution channel segment in the neonatal jaundice management market.
In 2021, the direct tender segment is anticipated to hold the largest share of the global neonatal jaundice management market because phototherapy devices or equipment's are costly and require multiple vendor analysis to purchase the device. The direct tender segment is growing with a CAGR of 6.3% in the forecast period of 2021 to 2028.
Major Players
Data Bridge Market Research recognizes the following companies as the major Neonatal jaundice management market players in Neonatal jaundice management market are Medical Corp. (U.S.), avihealthcare (India), GENERAL ELECTRIC COMPANY (U.S.), Ibis Medical (India), Natus Medical Incorporated (U.S.), Ningbo David Medical (China), Weyer GmbH (Germany), Signify Holding (Netherlands).
Market Development
- In November 2020, Natus Medical Incorporated had announced the acquisition of Babye GmbH. Natus has also acquired its patented unique product, a remote that is utilized for mother-to-baby communication, along with the company. This technology is advantageous because it allows the mother and the infant to be connected during neonatal care. Heartbeat, vocal sounds, and respiration were used to connect them. The company was able to expand its product offering in the infant care area as a result of this acquisition.
Regional Analysis
Geographically, the countries covered in the neonatal jaundice management market report are U.S., Canada, Mexico, U.K., Germany, Italy, France, Spain, Russia, Netherland, Switzerland, Turkey, Belgium, Rest of Europe, China, India, Japan, Australia, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in Neonatal jaundice management market during the forecast period 2021 - 2028
North America will continue to dominate the Neonatal jaundice management market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period due to the increasing healthcare expenditure and well-established healthcare infrastructure in this region.
Asia-Pacific is estimated to be the fastest-growing region in Neonatal jaundice management market the forecast period 2021 - 2028
Asia-Pacific region is anticipated to grow at the highest rate during the forecast period of 2021-2028 due to the surging infant population and rise in the prevalence of neonatal jaundice in the region. Additionally, healthcare infrastructure modernization and the rising level of foreign investments in developing nations such as India and China are anticipated to enhance the market's growth rate.
COVID-19 Impact Analysis
The COVID-19 pandemic had a severe influence on the healthcare market, and it is estimated to have a long-term impact on the neonatal jaundice management industry. This virus spread quickly over the world, killing a large number of people. COVID-19 was labeled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The supply chain slowness hampered the neonatal jaundice management market.
However, the rising number of patients with COVID and the severity of the disease raise the risk of health consequences. Because of concerns about the health of new-born newborns, the demand for various neonatal jaundice treatments has surged. Concerns about the spread of COVID-19 infection have also led to an increase in demand for home care services around the world.
For more detailed information about the neonatal jaundice management market report, click here – https://www.databridgemarketresearch.com/fr/reports/global-neonatal-jaundice-treatment-market
